PLL

Pall Introduces 13 mm Acrodisc® MS Syringe Filter Certified for Low LCMS Extractables in Small Samples

[at noodls] – PORT WASHINGTON, N.Y., February 28, 2013 – Pall Corporation (NYSE:PLL) has introduced a 13 mm Acrodisc® MS syringe filter certified for low extractables in high performance liquid chromatography/mass spectrometry … moreView todays social media effects on PLLView the latest stocks trending across Twitter. Click to view dashboardSee who Pall is hiring next, click here to view […]

ForteBio Launches New Dip and Readâ„¢ Anti-FLAG Biosensor to Facilitate Protein Research and Drug Development

[at noodls] – PORT WASHINGTON, N.Y., February 12, 2013 – ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical … moreView todays social media effects on PLLView the latest stocks trending across Twitter. Click to view dashboardSee who Pall is hiring next, click here to view […]

Pall Corporation Provides Webcast Details for Second Quarter Fiscal 2013 Financial Results

[at noodls] – PORT WASHINGTON, N.Y., February 06, 2013 – Pall Corporation (NYSE:PLL) will report second quarter fiscal 2013 financial results on Wednesday, February 27, 2013 after 5:00 p.m. ET. A conference call to … moreView todays social media effects on PLLView the latest stocks trending across Twitter. Click to view dashboardSee who Pall is hiring next, click here to […]

Pall Corporation Magnifies Focus on Instrumentation with Expansion of Menlo Park Facility

[at noodls] – California Center of Excellence to Become Design Authority for Pall Instrumentation Development PORT WASHINGTON, N.Y., January 10, 2013 – Pall Corporation (NYSE:PLL), a global leader in filtration, separation … moreView todays social media effects on PLLView the latest stocks trending across Twitter. Click to view dashboardSee who Pall is hiring next, click here to view […]

ForteBio Launches Dip and Readâ„¢ Anti-Human Fab-CH1 Biosensor to Accelerate Human Biotherapeutic Drug Development

[at noodls] – PORT WASHINGTON, N.Y., January 09, 2013 – ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical … moreView todays social media effects on PLLView the latest stocks trending across Twitter. Click to view dashboardSee who Pall is hiring next, click here to view […]

Pall Corporation Names R. Brent Jones Treasurer

[at noodls] – PORT WASHINGTON, N.Y., January 07, 2013 – Pall Corporation (NYSE:PLL) announced today that R. Brent Jones has been appointed Treasurer, effective immediately. Mr. Jones, who joined Pall as VP of Finance … moreView todays social media effects on PLLView the latest stocks trending across Twitter. Click to view dashboardSee who Pall is hiring next, click here to […]

Pall Corp. to Present Membrane-Based Separation Solutions for Alternative Fuels

[at noodls] – PORT WASHINGTON, N.Y., November 21, 2012 – Driven by the demand for alternatives to fossil fuels and the challenge to mitigate carbon emissions, algae biomass industry executives around the world are striving … moreView todays social media effects on PLLView the latest stocks trending across Twitter. Click to view dashboard […]